• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体细胞线粒体DNA突变负担塑造白血病发生中的代谢可塑性。

Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis.

作者信息

Li-Harms Xiujie, Lu Jingjun, Fukuda Yu, Lynch John, Sheth Aditya, Pareek Gautam, Kaminski Marcin M, Ross Hailey S, Wright Christopher W, Smith Amber L, Wu Huiyun, Wang Yong-Dong, Valentine Marc, Neale Geoffrey, Vogel Peter, Pounds Stanley, Schuetz John D, Ni Min, Kundu Mondira

机构信息

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.

出版信息

Sci Adv. 2025 Jan 3;11(1):eads8489. doi: 10.1126/sciadv.ads8489. Epub 2025 Jan 1.

DOI:10.1126/sciadv.ads8489
PMID:39742470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11691655/
Abstract

The role of somatic mitochondrial DNA (mtDNA) mutations in leukemogenesis remains poorly characterized. To determine the impact of somatic mtDNA mutations on this process, we assessed the leukemogenic potential of hematopoietic progenitor cells (HPCs) from mtDNA mutator mice (Polg D257A) with or without NMyc overexpression. We observed a higher incidence of spontaneous leukemogenesis in recipients transplanted with heterozygous Polg HPCs and a lower incidence of NMyc-driven leukemia in those with homozygous Polg HPCs compared to controls. Although mtDNA mutations in heterozygous and homozygous HPCs caused similar baseline impairments in mitochondrial function, only heterozygous HPCs responded to and supported altered metabolic demands associated with NMyc overexpression. Homozygous HPCs showed altered glucose utilization with pyruvate dehydrogenase inhibition due to increased phosphorylation, exacerbated by NMyc overexpression. The impaired growth of NMyc-expressing homozygous HPCs was partially rescued by inhibiting pyruvate dehydrogenase kinase, highlighting a relationship between mtDNA mutation burden and metabolic plasticity in leukemogenesis.

摘要

体细胞线粒体DNA(mtDNA)突变在白血病发生中的作用仍未得到充分表征。为了确定体细胞mtDNA突变对这一过程的影响,我们评估了来自mtDNA突变小鼠(Polg D257A)的造血祖细胞(HPC)在有或无NMyc过表达情况下的白血病发生潜能。我们观察到,与对照组相比,接受杂合Polg HPC移植的受体自发白血病发生率更高,而接受纯合Polg HPC移植的受体中NMyc驱动的白血病发生率更低。尽管杂合和纯合HPC中的mtDNA突变在线粒体功能方面引起了类似的基线损伤,但只有杂合HPC对与NMyc过表达相关的代谢需求改变有反应并提供支持。纯合HPC由于磷酸化增加而表现出丙酮酸脱氢酶抑制导致的葡萄糖利用改变,NMyc过表达使其加剧。通过抑制丙酮酸脱氢酶激酶,表达NMyc的纯合HPC受损的生长得到部分挽救,这突出了白血病发生中mtDNA突变负担与代谢可塑性之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/e21ffd8b769b/sciadv.ads8489-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/4eca5bbf7ac4/sciadv.ads8489-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/e9edf35b5a01/sciadv.ads8489-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/488e2ed98c52/sciadv.ads8489-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/24d0b0fae578/sciadv.ads8489-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/0540b2366ab3/sciadv.ads8489-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/6a6cb06a5504/sciadv.ads8489-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/e21ffd8b769b/sciadv.ads8489-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/4eca5bbf7ac4/sciadv.ads8489-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/e9edf35b5a01/sciadv.ads8489-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/488e2ed98c52/sciadv.ads8489-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/24d0b0fae578/sciadv.ads8489-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/0540b2366ab3/sciadv.ads8489-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/6a6cb06a5504/sciadv.ads8489-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa1/11691655/e21ffd8b769b/sciadv.ads8489-f7.jpg

相似文献

1
Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis.体细胞线粒体DNA突变负担塑造白血病发生中的代谢可塑性。
Sci Adv. 2025 Jan 3;11(1):eads8489. doi: 10.1126/sciadv.ads8489. Epub 2025 Jan 1.
2
Modeling aging and retinal degeneration with mitochondrial DNA mutation burden.用线粒体 DNA 突变负担模拟衰老和视网膜变性。
Aging Cell. 2024 Nov;23(11):e14282. doi: 10.1111/acel.14282. Epub 2024 Aug 29.
3
Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice.杂合和纯合 POLG 突变小鼠的行为和代谢特征。
Mitochondrion. 2013 Jul;13(4):282-91. doi: 10.1016/j.mito.2013.03.006. Epub 2013 Mar 27.
4
The mtDNA mutation spectrum in the PolG mutator mouse reveals germline and somatic selection.PolG 突变体小鼠的 mtDNA 突变谱揭示了种系和体细胞选择。
BMC Genom Data. 2021 Nov 26;22(1):52. doi: 10.1186/s12863-021-01005-x.
5
Mitochondrial DNA Instability Supersedes Parkin Mutations in Driving Mitochondrial Proteomic Alterations and Functional Deficits in Polg Mutator Mice.线粒体 DNA 不稳定性超越 Parkin 突变,驱动 Polg 突变体小鼠的线粒体蛋白质组改变和功能缺陷。
Int J Mol Sci. 2024 Jun 11;25(12):6441. doi: 10.3390/ijms25126441.
6
Heterozygous p.Y955C mutation in DNA polymerase γ leads to alterations in bioenergetics, complex I subunit expression, and mtDNA replication.DNA 聚合酶 γ 中的杂合 p.Y955C 突变导致生物能量、复合物 I 亚基表达和 mtDNA 复制的改变。
J Biol Chem. 2022 Aug;298(8):102196. doi: 10.1016/j.jbc.2022.102196. Epub 2022 Jun 24.
7
Somatic mitochondrial DNA mutations do not increase neuronal vulnerability to MPTP in young POLG mutator mice.在年轻的POLG突变小鼠中,体细胞线粒体DNA突变不会增加神经元对MPTP的易感性。
Neurotoxicol Teratol. 2014 Nov-Dec;46:62-7. doi: 10.1016/j.ntt.2014.10.004.
8
NAD dependent UPR activation underlies intestinal aging caused by mitochondrial DNA mutations.NAD 依赖性 UPR 的激活是由线粒体 DNA 突变引起的肠道衰老的基础。
Nat Commun. 2024 Jan 16;15(1):546. doi: 10.1038/s41467-024-44808-z.
9
Voluntary wheel running has no impact on brain and liver mitochondrial DNA copy number or mutation measures in the PolG mouse model of aging.自愿轮跑对衰老的 PolG 小鼠模型的大脑和肝脏线粒体 DNA 拷贝数或突变测量没有影响。
PLoS One. 2020 Mar 2;15(3):e0226860. doi: 10.1371/journal.pone.0226860. eCollection 2020.
10
In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells.在培养的人类细胞中表达的人类线粒体DNA聚合酶POLG的体内功能分析。
J Biol Chem. 2000 Aug 11;275(32):24818-28. doi: 10.1074/jbc.M000559200.

本文引用的文献

1
Activation of Neurotoxic Astrocytes Due to Mitochondrial Dysfunction Triggered by Mutation.由于突变导致线粒体功能障碍而引发的神经毒性星形胶质细胞的激活。
Int J Biol Sci. 2024 May 11;20(8):2860-2880. doi: 10.7150/ijbs.93445. eCollection 2024.
2
NAD dependent UPR activation underlies intestinal aging caused by mitochondrial DNA mutations.NAD 依赖性 UPR 的激活是由线粒体 DNA 突变引起的肠道衰老的基础。
Nat Commun. 2024 Jan 16;15(1):546. doi: 10.1038/s41467-024-44808-z.
3
Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis.
线粒体氧化磷酸化和糖酵解引起的代谢可塑性在肿瘤发生的起始和进展中的调节作用。
Int J Mol Sci. 2023 Apr 11;24(8):7076. doi: 10.3390/ijms24087076.
4
Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy.癌症干细胞中代谢可塑性的调控及其在癌症治疗中的意义
Cancers (Basel). 2022 Nov 30;14(23):5912. doi: 10.3390/cancers14235912.
5
Mitochondrial DNA mutations in ageing and cancer.线粒体 DNA 突变与衰老和癌症。
Mol Oncol. 2022 Sep;16(18):3276-3294. doi: 10.1002/1878-0261.13291. Epub 2022 Jul 28.
6
Mitochondrial RNA modifications shape metabolic plasticity in metastasis.线粒体 RNA 修饰塑造转移中的代谢可塑性。
Nature. 2022 Jul;607(7919):593-603. doi: 10.1038/s41586-022-04898-5. Epub 2022 Jun 29.
7
The mtDNA mutation spectrum in the PolG mutator mouse reveals germline and somatic selection.PolG 突变体小鼠的 mtDNA 突变谱揭示了种系和体细胞选择。
BMC Genom Data. 2021 Nov 26;22(1):52. doi: 10.1186/s12863-021-01005-x.
8
Cancer metabolism: looking forward.癌症代谢:展望未来。
Nat Rev Cancer. 2021 Oct;21(10):669-680. doi: 10.1038/s41568-021-00378-6. Epub 2021 Jul 16.
9
Mitochondrial DNA variation and cancer.线粒体 DNA 变异与癌症。
Nat Rev Cancer. 2021 Jul;21(7):431-445. doi: 10.1038/s41568-021-00358-w. Epub 2021 May 27.
10
PHGDH as a mechanism for resistance in metabolically-driven cancers.磷酸甘油酸脱氢酶(PHGDH)作为代谢驱动型癌症耐药的一种机制。
Cancer Drug Resist. 2020;3(4):762-774. doi: 10.20517/cdr.2020.46. Epub 2020 Sep 17.